tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CTMX Stock Latest News

Promising Developments in CytomX Therapeutics’ Clinical Trials Boost Buy Rating for CX-801
RatingsPromising Developments in CytomX Therapeutics’ Clinical Trials Boost Buy Rating for CX-801
3d ago
CTMX
CytomX Therapeutics announces first patient dosed in Phase 1 study of CX-801
PremiumThe Fly
CytomX Therapeutics announces first patient dosed in Phase 1 study of CX-801
4d ago
CTMX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
8d ago
BMY
ABBV
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
8d ago
C
AA
CytomX Therapeutics price target raised to $5 from $2.50 at Piper Sandler
PremiumThe Fly
CytomX Therapeutics price target raised to $5 from $2.50 at Piper Sandler
8d ago
CTMX
Promising Clinical Data and Safety Profile Lead to Buy Rating for CytomX Therapeutics’ CX-2051
PremiumRatingsPromising Clinical Data and Safety Profile Lead to Buy Rating for CytomX Therapeutics’ CX-2051
8d ago
CTMX
CytomX Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
CytomX Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
8d ago
CTMX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9d ago
BMY
XLO
CytomX Therapeutics Secures $93.4 Million Through Stock Sale
PremiumCompany Announcements
CytomX Therapeutics Secures $93.4 Million Through Stock Sale
9d ago
8K
CTMX
3 Penny Stocks to Watch Now, 5/13/25
PremiumMarket News
3 Penny Stocks to Watch Now, 5/13/25
10d ago
CTMX
DEVS
CytomX Therapeutics Reports Q1 2025 Results and Progress
PremiumCompany Announcements
CytomX Therapeutics Reports Q1 2025 Results and Progress
10d ago
CTMX
CytomX Therapeutics 76.9M share Secondary priced at $1.30
PremiumThe Fly
CytomX Therapeutics 76.9M share Secondary priced at $1.30
11d ago
CTMX
CytomX Therapeutics Reports Positive Interim Phase 1 Data
PremiumCompany AnnouncementsCytomX Therapeutics Reports Positive Interim Phase 1 Data
11d ago
8K
CTMX
CytomX Therapeutics reports Q1 EPS 27c, consensus 13c
Premium
The Fly
CytomX Therapeutics reports Q1 EPS 27c, consensus 13c
11d ago
CTMX
CytomX reports results from interim Phase 1 data for CX-2051
Premium
The Fly
CytomX reports results from interim Phase 1 data for CX-2051
11d ago
CTMX
CTMX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CTMX Earnings this Week: How Will it Perform?
18d ago
CTMX
CytomX Therapeutics assumed with an Overweight at Piper Sandler
PremiumThe Fly
CytomX Therapeutics assumed with an Overweight at Piper Sandler
1M ago
CTMX
CytomX Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
CytomX Therapeutics participates in a conference call with JPMorgan
2M ago
CTMX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
BMY
ABBV
CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability
PremiumCompany AnnouncementsCytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability
3M ago
CTMX
CytomX Therapeutics’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
CytomX Therapeutics’ Earnings Call Highlights Progress and Challenges
3M ago
CTMX
Cautious Outlook for CytomX Therapeutics Amid Pipeline Challenges and Strategic Setbacks
Premium
Ratings
Cautious Outlook for CytomX Therapeutics Amid Pipeline Challenges and Strategic Setbacks
3M ago
CTMX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >